The clinical research of intravenous thrombolysis with alteplase in the treatment for acute ischemic stroke
<strong>Objective</strong> The incidence of stroke in China has been growing year by year and has become the first cause of death exceeding cancer and heart disease. However, non-standard thrombolytic drug dose and therapeutic time window have seriously affected the treating effect of ac...
Main Authors: | Pei-lan ZHANG, Chen-hao ZHANG, Yan CHEN, Chen-hua LI, Yu-xin WANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Tianjin Huanhu Hospital
2013-04-01
|
Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
Subjects: | |
Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/699 |
Similar Items
-
Investigation of the causes of clinical symptom aggravation in process of intravenous thrombolysis with alteplase
by: Chen-hao ZHANG, et al.
Published: (2013-04-01) -
Actively developing intravenous thrombolysis for acute ischemic stroke
by: Jin-huan WANG
Published: (2013-04-01) -
Efficacy and safety of thrombolysis in treatment of minor stroke
by: Guang⁃hua LI, et al.
Published: (2020-10-01) -
Treatment analysis of intravenous thrombolysis in patients with mild ischemic stroke
by: Zhao⁃hui SONG, et al.
Published: (2019-12-01) -
Frequency and predictors of symptomatic intracranial hemorrhage after intravenous thrombolysis for acute ischemic stroke in a Brazilian public hospital
by: Pedro Telles Cougo-Pinto, et al.
Published: (2012-07-01)